487 related articles for article (PubMed ID: 32205444)
1. 15-Epi-LXA
Sekheri M; El Kebir D; Edner N; Filep JG
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7971-7980. PubMed ID: 32205444
[TBL] [Abstract][Full Text] [Related]
2. Interferon-β regulates proresolving lipids to promote the resolution of acute airway inflammation.
Sekheri M; Rizo-Téllez SA; Othman A; El Kebir D; Filep JG
Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2201146119. PubMed ID: 35878041
[TBL] [Abstract][Full Text] [Related]
3. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.
Wang H; Anthony D; Yatmaz S; Wijburg O; Satzke C; Levy B; Vlahos R; Bozinovski S
Clin Sci (Lond); 2017 Sep; 131(18):2347-2362. PubMed ID: 28779028
[TBL] [Abstract][Full Text] [Related]
4. Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation.
Abdulnour RE; Sham HP; Douda DN; Colas RA; Dalli J; Bai Y; Ai X; Serhan CN; Levy BD
Mucosal Immunol; 2016 Sep; 9(5):1278-87. PubMed ID: 26647716
[TBL] [Abstract][Full Text] [Related]
5. 15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury.
El Kebir D; József L; Pan W; Wang L; Petasis NA; Serhan CN; Filep JG
Am J Respir Crit Care Med; 2009 Aug; 180(4):311-9. PubMed ID: 19483113
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
Takano T; Clish CB; Gronert K; Petasis N; Serhan CN
J Clin Invest; 1998 Feb; 101(4):819-26. PubMed ID: 9466977
[TBL] [Abstract][Full Text] [Related]
7. Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.
Brancaleone V; Dalli J; Bena S; Flower RJ; Cirino G; Perretti M
J Immunol; 2011 Apr; 186(8):4905-14. PubMed ID: 21398608
[TBL] [Abstract][Full Text] [Related]
8. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
Takano T; Fiore S; Maddox JF; Brady HR; Petasis NA; Serhan CN
J Exp Med; 1997 May; 185(9):1693-704. PubMed ID: 9151906
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the lipoxin A4 and resolvin D1 receptor impairs host response to acute lung injury caused by pneumococcal pneumonia in mice.
Siegel ER; Croze RH; Fang X; Matthay MA; Gotts JE
Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L1085-L1092. PubMed ID: 33822656
[TBL] [Abstract][Full Text] [Related]
10. Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis.
Lee HN; Surh YJ
Biochem Pharmacol; 2013 Sep; 86(6):759-69. PubMed ID: 23856291
[TBL] [Abstract][Full Text] [Related]
11. Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent.
Orr SK; Colas RA; Dalli J; Chiang N; Serhan CN
Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L904-11. PubMed ID: 25770181
[TBL] [Abstract][Full Text] [Related]
12. Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function.
Planagumà A; Domenech T; Jover I; Ramos I; Sentellas S; Malhotra R; Miralpeix M
Clin Exp Immunol; 2013 Aug; 173(2):298-309. PubMed ID: 23607720
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages.
Godson C; Mitchell S; Harvey K; Petasis NA; Hogg N; Brady HR
J Immunol; 2000 Feb; 164(4):1663-7. PubMed ID: 10657608
[TBL] [Abstract][Full Text] [Related]
14. Aspirin-triggered lipoxin A4 (15-epi-LXA4) increases the endothelial viability of human corneas storage in Optisol-GS.
He J; Kakazu AH; Bazan NG; Bazan HE
J Ocul Pharmacol Ther; 2011 Jun; 27(3):235-41. PubMed ID: 21548792
[TBL] [Abstract][Full Text] [Related]
15. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.
Krishnamoorthy S; Recchiuti A; Chiang N; Fredman G; Serhan CN
Am J Pathol; 2012 May; 180(5):2018-27. PubMed ID: 22449948
[TBL] [Abstract][Full Text] [Related]
16. Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.
Motwani MP; Colas RA; George MJ; Flint JD; Dalli J; Richard-Loendt A; De Maeyer RP; Serhan CN; Gilroy DW
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563331
[TBL] [Abstract][Full Text] [Related]
17. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
[TBL] [Abstract][Full Text] [Related]
18. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
[TBL] [Abstract][Full Text] [Related]
19. 15-epi-Lipoxin A
Sham HP; Walker KH; Abdulnour RE; Krishnamoorthy N; Douda DN; Norris PC; Barkas I; Benito-Figueroa S; Colby JK; Serhan CN; Levy BD
J Immunol; 2018 Apr; 200(8):2757-2766. PubMed ID: 29523657
[TBL] [Abstract][Full Text] [Related]
20. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
Parkinson JF
Inflamm Allergy Drug Targets; 2006 Apr; 5(2):91-106. PubMed ID: 16613568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
